Kidswell Bio Corporation (4584.T)
JPY 102.0
(-7.27%)
JPY 102.0
(-7.27%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.57 Billion JPY | 32.05% |
| 2022 | 1.95 Billion JPY | 178.57% |
| 2021 | 700 Million JPY | -36.36% |
| 2020 | 1.1 Billion JPY | -10.2% |
| 2019 | 1.22 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.4 Billion JPY | -6.71% |
| 2023 Q1 | 1.85 Billion JPY | -5.13% |
| 2023 Q4 | 2.57 Billion JPY | 13.19% |
| 2023 Q3 | 2.27 Billion JPY | 28.17% |
| 2023 Q2 | 1.77 Billion JPY | -4.05% |
| 2023 FY | 2.57 Billion JPY | 32.05% |
| 2022 Q2 | 2.17 Billion JPY | 0.0% |
| 2022 FY | 1.95 Billion JPY | 178.57% |
| 2022 Q4 | 1.95 Billion JPY | -6.02% |
| 2022 Q3 | 2.07 Billion JPY | -4.6% |
| 2021 FY | 700 Million JPY | -36.36% |
| 2020 FY | 1.1 Billion JPY | -10.2% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 2.46 Billion JPY | -4.264% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 3.69 Billion JPY | 30.395% |
| Linical Co., Ltd. | 3 Billion JPY | 14.221% |
| Trans Genic Inc. | 2.25 Billion JPY | -14.086% |
| MEDINET Co., Ltd. | 2.3 Million JPY | -111516.818% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.47 Billion JPY | -4.177% |
| AnGes, Inc. | 362.67 Million JPY | -610.002% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -2309.943% |
| Nxera Pharma Co., Ltd. | 73.97 Billion JPY | 96.519% |
| Immuno-Biological Laboratories Co., Ltd. | 235.98 Million JPY | -991.185% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | -132.209% |
| Carna Biosciences, Inc. | 182.97 Million JPY | -1307.327% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 885.12 Million JPY | -190.92% |
| RaQualia Pharma Inc. | 367.71 Million JPY | -600.265% |
| Chiome Bioscience Inc. | 291 Million JPY | -784.88% |
| PeptiDream Inc. | 22.79 Billion JPY | 88.706% |
| Oncolys BioPharma Inc. | 315.17 Million JPY | -717.019% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 665 Million JPY | -287.218% |
| Healios K.K. | 4.53 Billion JPY | 43.182% |
| BrightPath Biotherapeutics Co., Ltd. | 112.5 Million JPY | -2188.889% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 142.85 Million JPY | -1702.552% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 97.54 Million JPY | -2539.888% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 933.3 Million JPY | -175.903% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 968 Million JPY | -166.012% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 723.93 Million JPY | -255.697% |
| StemCell Institute Inc. | 8.78 Million JPY | -29214.663% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 151.25 Million JPY | -1602.479% |